Related Experiment Video
Updated: Mar 2, 2026
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Paradoxical effect of minocycline on established neuropathic pain in rat
Malek Zarei1, Masoumeh Sabetkasaei1, Taraneh Moini-Zanjani1
1Department of Pharmacology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Neuropathic pain occurs after peripheral nerve damage, inflammation or infection. In this situation, microglial cells become activated and play a key role in producing pain. Minocycline (microglia inhibitor), was reported to reduce pain when used preventively. However, it seems that, when used after nerve injury, results in its pain reducing effects are different. In this regard, to assess the pain reducing differences of minocycline, neuropathic pain was induced by the ligation of the sciatic nerve in the rat which is recognized as chronic constriction injury (CCI) and minocycline was administered before and after sciatic nerve injury. Wistar male rats (200-250 g, n=6) were used in these experiments. Rats were distributed in various groups: vehicle-treated CCI (control), sham-operated and minocycline-treated CCI groups. In the first part of the experiment (pre-injury study), minocycline (10, 20, 30 and 40 mg/kg,) was injected one hour before surgery and then daily for two weeks. In the second part (post injury study), minocycline was administered: 1: at day one after nerve damage once a day to day 14, 2: at day seven after surgery and continued daily until day 14. Analgesimeter for thermal hyperalgesia and von Frey hairs for mechanical allodynia were used to evaluate pain behavior. Thermal hyperalgesia and mechanical allodynia were attenuated significantly, when minocycline used before surgery, while it was not able to reduce pain behavior administered after surgery. It seems that, in spite of what some previous studies have reported, here, minocycline is not able to attenuate established neuropathic pain.
Insights
Minocycline effectively reduces neuropathic pain when given preventively before nerve injury. However, this microglia inhibitor fails to alleviate established pain when administered after the injury occurs.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Neuropathic pain arises from nerve damage, inflammation, or infection, involving activated microglial cells.
- Minocycline, a microglia inhibitor, has shown pain-reducing effects when used preventively.
- The efficacy of minocycline in established neuropathic pain remains less understood.
Purpose of the Study:
- To investigate the differential effects of minocycline on neuropathic pain based on administration timing.
- To assess minocycline's efficacy when administered before versus after sciatic nerve injury (Chronic Constriction Injury model).
Main Methods:
- Neuropathic pain was induced in Wistar rats using the Chronic Constriction Injury (CCI) model.
- Minocycline was administered either one hour before surgery and daily for two weeks, or starting one or seven days after surgery.
- Pain behaviors, including thermal hyperalgesia and mechanical allodynia, were evaluated using established tests.
Main Results:
- Pre-injury administration of minocycline significantly attenuated thermal hyperalgesia and mechanical allodynia.
- Post-injury administration of minocycline, whether initiated one or seven days after nerve damage, did not reduce pain behaviors.
- Established neuropathic pain in the CCI model was not alleviated by minocycline treatment.
Conclusions:
- Minocycline demonstrates significant pain-reducing effects when administered prophylactically before nerve injury.
- Minocycline is ineffective in attenuating established neuropathic pain when treatment begins after nerve damage.
- The timing of minocycline administration is critical for its therapeutic efficacy in neuropathic pain models.
